Login to Your Account



Financings Roundup

Ziopharm Offering Could Raise $63.5M for Trials Expansion

By Tom Wall


Friday, February 4, 2011
Ziopharm Oncology Inc. could raise as much as $63.5 million through an underwritten public offering of 9.6 million shares of common stock priced at $5.75 per share – about 7 percent below Wednesday's closing price – and an underwriter's 30-day option to purchase as many as 1.4 million additional shares.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription